SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,656.09 286.98
( 0.37%)

Global Indices

Nasdaq

53,439.07 141.06
(0.26%)

Dow Jones

7,673.94 -21.43
(-0.28%)

Hang Seng

65,802.43 274.34
(0.42%)

Nikkei 225

10,857.89 41.33
(0.38%)

Forex

USD-INR

95.63 -0.04
(-0.04%)

EUR-INR

111.66 -0.10
(-0.09%)

GBP-INR

130.46 0.10
(0.08%)

JPY-INR

0.60 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Hester Biosciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524669

INE782E01017

452.7894412

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HESTERBIO

37.42

2008.47

EPS(TTM)

Face Value()

Div & Yield %

63.1

0.47

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	292.14	286.47	285.16	254.00	219.35	208.48
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	292.14	286.47	285.16	254.00	219.35	208.48
Other Income	14.63	4.76	4.26	5.32	4.66	1.65
Stock Adjustments	3.69	-9.97	-10.36	4.77	12.53	-4.01
Total Income	310.46	281.26	279.06	264.09	236.54	206.12
EXPENDITURE :
Raw Materials	85.66	83.70	89.28	84.65	76.37	49.38
Power & Fuel Cost	9.20	10.12	12.34	9.95	8.74	6.93
Employee Cost	53.17	54.76	56.72	47.92	39.12	33.45
Other Manufacturing Expenses	15.23	14.07	14.49	7.57	6.89	5.46
Selling & Administrative Expenses	49.88	54.45	50.25	49.26	34.94	32.24
Miscellaneous Expenses	10.21	8.46	4.37	4.55	5.26	10.28
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	223.36	225.56	227.45	203.88	171.31	137.74
Operating Profit	87.10	55.71	51.60	60.21	65.23	68.37
Interest	7.17	5.37	5.09	6.50	2.47	3.95
Gross Profit	79.93	50.34	46.51	53.71	62.76	64.42
Depreciation	10.25	8.58	9.78	9.79	9.50	9.63
Profit Before Tax	69.68	41.76	36.73	43.92	53.26	54.79
Tax	14.47	11.27	9.64	10.73	14.25	16.37
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	3.12	-1.35	-0.06	0.86	-0.51	-1.48
Reported Net Profit	52.10	31.84	27.16	32.34	39.52	39.90
Extraordinary Items	5.08	-0.35	0.02	0.01	0.09	-3.69
Adjusted Net Profit	47.02	32.19	27.14	32.33	39.43	43.59
Adjustment below Net Profit	-0.05	-0.36	-0.02	0.11	-0.16	0.21
P & L Balance brought forward	272.91	246.53	226.20	202.25	171.40	136.90
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	5.96	5.10	6.81	8.51	8.51	5.62
P & L Balance carried down	319.00	272.91	246.53	226.20	202.25	171.40
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	110.00	70.00	60.00	80.00	100.00	100.00
Dividend Per Share(Rs)	11.00	7.00	6.00	8.00	10.00	10.00
Earnings Per Share-Unit Curr	61.24	37.43	31.93	38.02	46.45	46.90
Earnings Per Share(Adj)-Unit Curr	61.24	37.43	31.93	38.02	46.45	46.90
Book Value-Unit Curr	452.78	398.60	367.59	343.70	315.54	279.28
Book Value(Adj)-Unit Curr	452.78	398.60	367.59	343.70	315.54	279.28

77,656.09 286.98 ( 0.37%)

53,439.07 141.06 (0.26%)

7,673.94 -21.43 (-0.28%)

65,802.43 274.34 (0.42%)

10,857.89 41.33 (0.38%)

95.63 -0.04 (-0.04%)

111.66 -0.10 (-0.09%)

130.46 0.10 (0.08%)

0.60 0.00 (-0.21%)